Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). EJRDI. 2023;26:1-4. Accessed June 18, 2026. https://mail.geniusjournals.org/index.php/ejrdi/article/view/5178